Skip to main content

Ripretinib User Reviews & Ratings

Brand names: Qinlock

Ripretinib has an average rating of 1.0 out of 10 from a total of 1 reviews on Drugs.com. 0% of reviewers reported a positive experience, while 100% reported a negative experience.

Condition Avg. Rating Reviews Compare
Gastrointestinal Stromal Tumor
1.0
1 reviews for Gastrointestinal Stromal Tumor 6 medications

Write a review

  • Bob...
  • Taken for 6 months to 1 year
  • March 14, 2023

For Gastrointestinal Stromal Tumor "For me, ripretinib (Qinlock) was a total failure. I spent 5 months on this drug, and my tumors mostly doubled in size in that time. The side effects were more pronounced and severe, including hair loss, fatigue, weight loss, than my previous time on Imatinib and Sunitinib. It was easy to use."

1 / 10
Was this helpful?YesNo
0 Report

See also:

Are you taking this medicine?

Your review helps others make informed decisions.
Write a review
Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.